Anti-cancer effects of novel flavonoid vicenin-2 as a single agent and in synergistic combination with docetaxel in prostate cancer
Keywords: CaP; carcinoma of prostate; VCN-2; vicenin-2; DTL; docetaxel; PCNA; proliferating cell nuclear antigen; AR; androgen receptor; Prostate cancer; Vicenin-2; Docetaxel; Tumor xenografts;